{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:57:34Z","timestamp":1781333854432,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejso.2026.111877","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:30:22Z","timestamp":1778628622000},"page":"111877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contemporary short-term post-operative outcomes after resection of entero-pancreatic NETs: a population-based study"],"prefix":"10.1016","volume":"52","author":[{"given":"L\u00e9amarie","family":"Meloche-Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simron","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-0871","authenticated-orcid":false,"given":"Calvin","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-673X","authenticated-orcid":false,"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Armah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.ejso.2026.111877_bib1","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111877_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejso.2026.111877_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa2403991","article-title":"Phase 3 trial of cabozantinib to treat advanced neuroendocrine tumors","volume":"392","author":"Chan","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejso.2026.111877_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-Dotatate for Midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"10446","key":"10.1016\/j.ejso.2026.111877_bib7","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib8","article-title":"Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: impact of expert centres","volume":"31","author":"Zandee","year":"2022","journal-title":"Eur J Cancer Care"},{"issue":"9","key":"10.1016\/j.ejso.2026.111877_bib9","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1245\/s10434-022-11837-1","article-title":"Radical resection in entero-pancreatic neuroendocrine tumors: recurrence-free survival rate and definition of a risk score for recurrence","volume":"29","author":"Merola","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111877_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pan.2026.01.079","article-title":"Prognostic and recurrence implications of subdividing WHO grade 2 pancreatic neuroendocrine tumors at a 10% Ki-67 threshold","volume":"26","author":"Choi","year":"2026","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jhbp.47","article-title":"Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification","volume":"21","author":"Tsutsumi","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"3","key":"10.1016\/j.ejso.2026.111877_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/SLA.0000000000003461","article-title":"A novel validated recurrence risk score to guide a pragmatic surveillance strategy after resection of pancreatic neuroendocrine tumors: an international study of 1006 patients","volume":"270","author":"Zaidi","year":"2019","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ejso.2026.111877_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using Observational Routinely-collected health Data (RECORD) Statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejso.2026.111877_bib14","author":"Canada"},{"issue":"13","key":"10.1016\/j.ejso.2026.111877_bib15","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.29338","article-title":"Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: a population-based analysis of 6271 cases","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.111877_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2026.111877_bib17","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1245\/s10434-017-5986-0","article-title":"Patterns and drivers of costs for neuroendocrine tumor care: a comparative population-based analysis","volume":"24","author":"Hallet","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111877_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0895-4356(88)90052-2","article-title":"An application of capture-recapture methods to the estimation of completeness of cancer registration","volume":"41","author":"Robles","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejso.2026.111877_bib19","first-page":"246","article-title":"Cancer registration in Ontario: a computer approach","volume":"95","author":"Clarke","year":"1991","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.ejso.2026.111877_bib20","unstructured":"Juurlink D, Preyra C, Croxford R. Canadian institute for health information discharge abstract database: a validation study."},{"issue":"2","key":"10.1016\/j.ejso.2026.111877_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111877_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0000000000001215","article-title":"Doubling of 30-Day mortality by 90 days after esophagectomy: a critical measure of outcomes for quality improvement","volume":"263","author":"In","year":"2016","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.ejso.2026.111877_bib23","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-014-4036-4","article-title":"The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the national cancer data base","volume":"21","author":"Swanson","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111877_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1477-2574.2011.00326.x","article-title":"Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion","volume":"13","author":"Mayo","year":"2011","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2026.111877_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae278","article-title":"Scoping review of days at home after surgery as a perioperative outcome: recommendations for use in health services research","author":"Ribeiro","year":"2024","journal-title":"BJS"},{"issue":"8","key":"10.1016\/j.ejso.2026.111877_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015828","article-title":"Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia","volume":"7","author":"Myles","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ejso.2026.111877_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/ALN.0000000000003123","article-title":"Socioeconomic status and days alive and out of Hospital after major elective noncardiac surgery: a population-based cohort study","volume":"132","author":"Jerath","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejso.2026.111877_bib28","first-page":"33","article-title":"Measuring \u201crurality\u201d for purposes of health-care planning: an empirical measure for Ontario","volume":"67","author":"Kralj","year":"2000","journal-title":"Ontario Med Rev"},{"issue":"8 Suppl 2","key":"10.1016\/j.ejso.2026.111877_bib29","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/BF03403823","article-title":"Development of the Canadian Marginalization index: a new tool for the study of inequality","volume":"103","author":"Matheson","year":"2012","journal-title":"Can J Public Health"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12913-018-3125-7","article-title":"Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data","volume":"18","author":"Mahar","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/1913643","volume":"46","author":"Koenker","year":"1978","journal-title":"Econometrica"},{"issue":"4","key":"10.1016\/j.ejso.2026.111877_bib33","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1213\/ANE.0000000000004017","article-title":"Quantile regression and its applications: a primer for anesthesiologists","volume":"128","author":"Staffa","year":"2019","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.ejso.2026.111877_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bmjqs-2021-013150","article-title":"Days alive and at home after hip fracture: a cross-sectional validation of a patient-centred outcome measure using routinely collected data","volume":"32","author":"McIsaac","year":"2023","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib35","article-title":"Pancreatic surgery outcomes: Multicentre prospective snapshot study in 67 countries","volume":"111","year":"2024","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.ejso.2026.111877_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13008","article-title":"Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: a systematic review and meta-analysis","volume":"33","author":"Ka\u00e7maz","year":"2021","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9610(99)80107-X","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas","volume":"169","author":"Que","year":"1995","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib38","first-page":"1091","article-title":"Cytoreductive hepatic surgery for neuroendocrine tumors","volume":"108","author":"McEntee","year":"1990","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.ejso.2026.111877_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.surg.2008.06.008","article-title":"The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors","volume":"144","author":"Chambers","year":"2008","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib40","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.surg.2014.08.009","article-title":"Expanded criteria for carcinoid liver debulking: maintaining survival and increasing the number of eligible patients","volume":"156","author":"Angb","year":"2014","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.surg.2015.05.040","article-title":"Liver-directed surgery of neuroendocrine metastases: what is the optimal strategy?","volume":"159","author":"Maxwell","year":"2016","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.surg.2018.04.070","article-title":"Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)","volume":"165","author":"Scott","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2026.111877_bib44","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1245\/s10434-023-13372-z","article-title":"Survival and symptomatic relief after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: long-term Follow-up evaluation of more than 500 patients","volume":"30","author":"Gudmundsdottir","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0272989X16636113","article-title":"Extent and predictors of decision regret about health care decisions: a systematic review","volume":"36","author":"Becerra P\u00e9rez","year":"2016","journal-title":"Med Decis Mak"},{"issue":"4","key":"10.1016\/j.ejso.2026.111877_bib46","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpainsymman.2018.11.017","article-title":"Validity and reliability of the decision regret scale in cancer patients receiving adjuvant chemotherapy","volume":"57","author":"Calderon","year":"2019","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"10.1016\/j.ejso.2026.111877_bib47","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s00268-017-3895-9","article-title":"Regret in surgical decision making: a systematic review of patient and physician perspectives","volume":"41","author":"Wilson","year":"2017","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.ejso.2026.111877_bib48","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamaoto.2019.3020","article-title":"Evaluation of older age and frailty as factors associated with depression and postoperative decision regret in patients undergoing major head and neck surgery","volume":"145","author":"Thomas","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.ejso.2026.111877_bib49","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pon.5362","article-title":"Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: a population-based patient-reported outcome study","volume":"29","author":"Wilding","year":"2020","journal-title":"Psychooncology"},{"issue":"9","key":"10.1016\/j.ejso.2026.111877_bib50","doi-asserted-by":"crossref","first-page":"znae178","DOI":"10.1093\/bjs\/znae178","article-title":"Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): Multicentre phase II study","volume":"111","author":"Partelli","year":"2024","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.ejso.2026.111877_bib51","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s11605-019-04232-x","article-title":"EndoVascular occlusion and Tumor Excision (EVOTE): a hybrid approach to small-bowel neuroendocrine tumors with mesenteric metastases","volume":"23","author":"Horwitz","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"Suppl 3","key":"10.1016\/j.ejso.2026.111877_bib52","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1245\/s10434-015-4620-2","article-title":"Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis","volume":"22","author":"Pasquer","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111877_bib53","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2017.12.262","article-title":"Association between treatment at high-volume facilities and improved overall survival in soft tissue sarcomas","volume":"100","author":"Venigalla","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ejso.2026.111877_bib54","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.hpb.2023.04.010","article-title":"Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer","volume":"25","author":"Servin-Rojas","year":"2023","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.ejso.2026.111877_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"issue":"12","key":"10.1016\/j.ejso.2026.111877_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13343","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours","volume":"35","author":"Kos-Kudla","year":"2023","journal-title":"J Neuroendocrinol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:46:49Z","timestamp":1781333209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0748798326004968"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111877","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary short-term post-operative outcomes after resection of entero-pancreatic NETs: a population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111877"}}